ASSET | DATE | % RETURN |
---|---|---|
Avalon GloboCare (ALBT) | 3/1/2018 - 3/31/2018 | 4,016,566.67% |
GT Biopharma (GTBP) | 3/1/2018 - 3/31/2018 | 50,111.34% |
Arcadia Biosciences (RKDA) | 3/1/2018 - 3/31/2018 | 426.54% |
TONX (TONX) | 3/1/2018 - 3/31/2018 | 222.22% |
INVO Fertility (IVF) | 3/1/2018 - 3/31/2018 | 217.65% |
Bone Biologics (BBLG) | 3/1/2018 - 3/31/2018 | 203.55% |
Aemetis (AMTX) | 3/1/2018 - 3/31/2018 | 198.25% |
Creative Medical Technology (CELZ) | 3/1/2018 - 3/31/2018 | 189.2% |
American Resources Corp Class A (AREC) | 3/1/2018 - 3/31/2018 | 168.68% |
Daxor (DXR) | 3/1/2018 - 3/31/2018 | 164.35% |
BlueLinx (BXC) | 3/1/2018 - 3/31/2018 | 110.26% |
Nocera (NCRA) | 3/1/2018 - 3/31/2018 | 98.82% |
Odyssey Marine Exploration (OMEX) | 3/1/2018 - 3/31/2018 | 95.51% |
Acm Research (ACMR) | 3/1/2018 - 3/31/2018 | 83.31% |
Geron (GERN) | 3/1/2018 - 3/31/2018 | 81.62% |
Kaival Brands Innovations (KAVL) | 3/1/2018 - 3/31/2018 | 77.78% |
CleanSpark (CLSK) | 3/1/2018 - 3/31/2018 | 74.45% |
Durect (DRRX) | 3/1/2018 - 3/31/2018 | 72.58% |
Clean Energy Technologies, Inc Common Stock (CETY) | 3/1/2018 - 3/31/2018 | 71.43% |
Focus Universal (FCUV) | 3/1/2018 - 3/31/2018 | 66% |
Clearside Biomedical (CLSD) | 3/1/2018 - 3/31/2018 | 65.59% |
LiqTech International (LIQT) | 3/1/2018 - 3/31/2018 | 63.14% |
Ameresco (AMRC) | 3/1/2018 - 3/31/2018 | 60.49% |
Syndax Pharmaceuticals (SNDX) | 3/1/2018 - 3/31/2018 | 59.53% |
Rafael (RFL) | 3/1/2018 - 3/31/2018 | 59.01% |